Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8159)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2015 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Wang JL, Du XF, Chen SL, Yu YQ, Wang J, Hu XQ, Shao LY, Chen JZ, Weng XH, Zhang WH. Histological outcome for chronic hepatitis B patients treated with entecavir |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v21/i32/9598.htm |
| Number | Citing Articles |
| 1 |
Yuanyuan Kong, Tingting Lv, Min Li, Lianghui Zhao, Tongtong Meng, Shanshan Wu, Wei Wei, Qian Zhang, Sha Chen, Hong You, Sabela Lens, Hitoshi Yoshiji, Sven Francque, Emmanouil Tsochatzis, Shiv K. Sarin, Mattias Mandorfer, Jidong Jia. Systematic review and meta-analysis: impact of anti-viral therapy on portal hypertensive complications in HBV patients with advanced chronic liver disease. Hepatology International 2022; 16(5): 1052 doi: 10.1007/s12072-022-10369-w
|
| 2 |
Guojun Li, Qiran Zhang, Yiqi Yu, Chao Qiu, Hanyue Zhang, Miaoqu Zhang, Zhangzhang Song, Yusheng Yang, Jiemin Hong, Jian Lu, Niuniu Li, Quanzhen Tang, Long Xu, Xuanyi Wang, Wenhong Zhang, Zhi Chen. Histological responses of peginterferon alpha add‐on therapy in patients with chronic hepatitis B with advanced liver fibrosis after long‐term nucleos(t)ide analog treatment. Journal of Viral Hepatitis 2019; 26(S1): 50 doi: 10.1111/jvh.13152
|
| 3 |
E K Ibragimov, D T Abdurakhmanov, T P Rozina, E N Nikulkina, E L Tanaschuk, A V Odintsov, S V Panevkina, S V Moiseev. Efficacy and safety of long-term therapy with nucleos(t)ide analogues in chronic hepatitis B. Terapevticheskii arkhiv 2019; 91(2): 40 doi: 10.26442/00403660.2019.02.000073
|
| 4 |
Gautam Ray. 5-year efficacy of entecavir in Indian patients with chronic hepatitis B. Indian Journal of Gastroenterology 2016; 35(3): 190 doi: 10.1007/s12664-016-0664-x
|
| 5 |
Qian Zhang, Da-Chuan Cai, Peng Hu, Hong Ren. Low-level viremia in nucleoside analog-treated chronic hepatitis B patients. Chinese Medical Journal 2021; 134(23): 2810 doi: 10.1097/CM9.0000000000001793
|
| 6 |
Sung Won Lee, Sung Min Kim, Wonhee Hur, Byung-Yoon Kang, Hae Lim Lee, Heechul Nam, Sun Hong Yoo, Pil Soo Sung, Jung Hyun Kwon, Jeong Won Jang, Seong-Jun Kim, Seung Kew Yoon, Partha Mukhopadhyay. Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell apoptosis via downregulation of PI3K/Akt/mTOR signaling pathway. PLOS ONE 2021; 16(12): e0261067 doi: 10.1371/journal.pone.0261067
|
| 7 |
Trung Doan Hieu, Chuong Tran Xuan. LIVER FIBROSIS RESPONSE TO ENTECAVIR TREATMENT IN PATIENTS WITH HBV-RELATED COMPENSATED CIRRHOSIS. Journal of Medicine and Pharmacy 2018; 8(6): 203 doi: 10.34071/jmp.2018.6.27
|
| 8 |
Emmanuel Thomas, T. Jake Liang. Experimental models of hepatitis B and C — new insights and progress. Nature Reviews Gastroenterology & Hepatology 2016; 13(6): 362 doi: 10.1038/nrgastro.2016.37
|
| 9 |
Tao Du, Bing Yu, Wei Luo. Liver cirrhosis reversal and recompensation: Existing evidence and future prospects. World Chinese Journal of Digestology 2024; 32(5): 320 doi: 10.11569/wcjd.v32.i5.320
|
| 10 |
Xiao-Dong Gai, Wei-Feng Wu. Effect of entecavir in the treatment of patients with hepatitis B virus-related compensated and decompensated cirrhosis. Experimental and Therapeutic Medicine 2017; 14(4): 3908 doi: 10.3892/etm.2017.4963
|
| 11 |
Maria Guido. Practical Hepatic Pathology: a Diagnostic Approach. 2018; : 671 doi: 10.1016/B978-0-323-42873-6.00040-8
|
| 12 |
Gang Qin, Jian-Guo Shao, Yong-Chang Zhu, Ai-Dong Xu, Jian-Hua Yao, Xu-Lin Wang, Yin-Kun Qian, Hua-Yu Wang, Yi Shen, Peng Lu, Lu-Jun Wang. Population-representative Incidence of Acute-On-Chronic Liver Failure. Journal of Clinical Gastroenterology 2016; 50(8): 670 doi: 10.1097/MCG.0000000000000538
|
| 13 |
Jing Wang, Yiqi Yu, Guojun Li, Chuan Shen, Zhefeng Meng, Jianming Zheng, Yanhong Jia, Shaolong Chen, Xiao Zhang, Mengqi Zhu, Jiangjiang Zheng, Zhangzhang Song, Jing Wu, Lingyun Shao, Peiyu Qian, Xiaona Mao, Xuanyi Wang, Yuxian Huang, Caiyan Zhao, Jiming Zhang, Chao Qiu, Wenhong Zhang. Relationship between serum HBV-RNA levels and intrahepatic viral as well as histologic activity markers in entecavir-treated patients. Journal of Hepatology 2018; 68(1): 16 doi: 10.1016/j.jhep.2017.08.021
|
| 14 |
Min-Ran Li, Huan-Wei Zheng, Shun-Mao Ma, Yun-Yan Liu, Lan-Xia Qie, Jun-Qing Li, De-Hua Wang, Xing-Li Sun, Gui-Fang Ren, Yan-Hua Zheng, Yu-Ling Wang, Er-Hei Dai. Correlations between serum hepatitis B surface antigen and hepatitis B core antibody titers and liver fibrosis in treatment-naïve CHB patients. Journal of the Chinese Medical Association 2018; 81(12): 1052 doi: 10.1016/j.jcma.2018.05.007
|
| 15 |
Qiran Zhang, Guojun Li, Yiqi Yu, Chao Qiu, Jianming Zheng, Hanyue Zhang, Miaoqu Zhang, Zhangzhang Song, Yusheng Yang, Xinfang Du, Jiemin Hong, Jian Lu, Niuniu Li, Quanzhen Tang, Long Xu, Xuanyi Wang, Yuxian Huang, Jiming Zhang, Zhi Chen, Wenhong Zhang. Histological response to combination therapy with nucleos(t)ide analogs and peginterferon alpha in treatment‐naïve chronic hepatitis B patients. Journal of Viral Hepatitis 2019; 26(S1): 59 doi: 10.1111/jvh.13153
|